Bayart E et al. |
A major role for mitotic CDC2 kinase inactivation in the establishment of the mitotic DNA damage checkpoint. |
2004 |
Cancer Res. |
pmid:15604258
|
Zhao LY et al. |
An EBF3-mediated transcriptional program that induces cell cycle arrest and apoptosis. |
2006 |
Cancer Res. |
pmid:17018599
|
Hellebrekers DM et al. |
Identification of epigenetically silenced genes in tumor endothelial cells. |
2007 |
Cancer Res. |
pmid:17483324
|
James SY et al. |
Regulation of retinoic acid receptor beta expression by peroxisome proliferator-activated receptor gamma ligands in cancer cells. |
2003 |
Cancer Res. |
pmid:12839938
|
Noh EJ et al. |
Methyl CpG-binding domain protein 3 mediates cancer-selective cytotoxicity by histone deacetylase inhibitors via differential transcriptional reprogramming in lung cancer cells. |
2005 |
Cancer Res. |
pmid:16357148
|
Setiadi AF et al. |
Epigenetic enhancement of antigen processing and presentation promotes immune recognition of tumors. |
2008 |
Cancer Res. |
pmid:19047136
|
Lau QC et al. |
RUNX3 is frequently inactivated by dual mechanisms of protein mislocalization and promoter hypermethylation in breast cancer. |
2006 |
Cancer Res. |
pmid:16818622
|
Foltz G et al. |
Genome-wide analysis of epigenetic silencing identifies BEX1 and BEX2 as candidate tumor suppressor genes in malignant glioma. |
2006 |
Cancer Res. |
pmid:16818640
|
Mori T et al. |
Estrogen receptor-alpha methylation predicts melanoma progression. |
2006 |
Cancer Res. |
pmid:16818643
|
Imre G et al. |
Histone deacetylase inhibitors suppress the inducibility of nuclear factor-kappaB by tumor necrosis factor-alpha receptor-1 down-regulation. |
2006 |
Cancer Res. |
pmid:16707469
|
Badia E et al. |
Long-term hydroxytamoxifen treatment of an MCF-7-derived breast cancer cell line irreversibly inhibits the expression of estrogenic genes through chromatin remodeling. |
2000 |
Cancer Res. |
pmid:10945620
|
Su GH et al. |
A novel histone deacetylase inhibitor identified by high-throughput transcriptional screening of a compound library. |
2000 |
Cancer Res. |
pmid:10866300
|
Lin F et al. |
Unique anti-activator protein-1 activity of retinoic acid receptor beta. |
2000 |
Cancer Res. |
pmid:10866321
|
Medina V et al. |
Induction of caspase-3 protease activity and apoptosis by butyrate and trichostatin A (inhibitors of histone deacetylase): dependence on protein synthesis and synergy with a mitochondrial/cytochrome c-dependent pathway. |
1997 |
Cancer Res. |
pmid:9288776
|
Ju R and Muller MT |
Histone deacetylase inhibitors activate p21(WAF1) expression via ATM. |
2003 |
Cancer Res. |
pmid:12782595
|
Xiong Y et al. |
Histone deacetylase inhibitors decrease DNA methyltransferase-3B messenger RNA stability and down-regulate de novo DNA methyltransferase activity in human endometrial cells. |
2005 |
Cancer Res. |
pmid:15805266
|
Ferrara FF et al. |
Histone deacetylase-targeted treatment restores retinoic acid signaling and differentiation in acute myeloid leukemia. |
2001 |
Cancer Res. |
pmid:11196162
|
Kumakura S et al. |
Reversible conversion of immortal human cells from telomerase-positive to telomerase-negative cells. |
2005 |
Cancer Res. |
pmid:15805278
|
Nishigaki M et al. |
Discovery of aberrant expression of R-RAS by cancer-linked DNA hypomethylation in gastric cancer using microarrays. |
2005 |
Cancer Res. |
pmid:15781621
|
Bai J et al. |
Predominant Bcl-XL knockdown disables antiapoptotic mechanisms: tumor necrosis factor-related apoptosis-inducing ligand-based triple chemotherapy overcomes chemoresistance in pancreatic cancer cells in vitro. |
2005 |
Cancer Res. |
pmid:15781649
|
Rahmani M et al. |
Coadministration of histone deacetylase inhibitors and perifosine synergistically induces apoptosis in human leukemia cells through Akt and ERK1/2 inactivation and the generation of ceramide and reactive oxygen species. |
2005 |
Cancer Res. |
pmid:15781658
|
Mizutani H et al. |
Romidepsin (FK228), a potent histone deacetylase inhibitor, induces apoptosis through the generation of hydrogen peroxide. |
2010 |
Cancer Sci. |
pmid:20624163
|
Sakuma M et al. |
Promoter methylation status of the Cyclin D2 gene is associated with poor prognosis in human epithelial ovarian cancer. |
2007 |
Cancer Sci. |
pmid:17270028
|
Tomosugi M et al. |
Retinoblastoma gene-independent G1 phase arrest by flavone, phosphatidylinositol 3-kinase inhibitor, and histone deacetylase inhibitor. |
2012 |
Cancer Sci. |
pmid:22957647
|
Chikamatsu K et al. |
Alteration of cancer stem cell-like phenotype by histone deacetylase inhibitors in squamous cell carcinoma of the head and neck. |
2013 |
Cancer Sci. |
pmid:23992541
|
Hattori N et al. |
Methylation silencing of angiopoietin-like 4 in rat and human mammary carcinomas. |
2011 |
Cancer Sci. |
pmid:21489049
|
Sasaki K et al. |
Histone deacetylase inhibitors trichostatin A and valproic acid circumvent apoptosis in human leukemic cells expressing the RUNX1 chimera. |
2008 |
Cancer Sci. |
pmid:18271940
|
Furumai R et al. |
Histone deacetylase inhibitors block nuclear factor-κB-dependent transcription by interfering with RNA polymerase II recruitment. |
2011 |
Cancer Sci. |
pmid:21299717
|
Yamada Y et al. |
Aberrant methylation of the vascular endothelial growth factor receptor-1 gene in prostate cancer. |
2003 |
Cancer Sci. |
pmid:12824880
|
Okada T et al. |
Identification of genes specifically methylated in Epstein-Barr virus-associated gastric carcinomas. |
2013 |
Cancer Sci. |
pmid:23829175
|
Akao Y et al. |
Downregulation of microRNAs-143 and -145 in B-cell malignancies. |
2007 |
Cancer Sci. |
pmid:17892514
|
Leng SL et al. |
Insulin-like growth factor-II renders LIM 2405 human colon cancer cells resistant to butyrate-induced apoptosis: a potential mechanism for colon cancer cell survival in vivo. |
2001 |
Carcinogenesis |
pmid:11577001
|
Ma J et al. |
Promoter hypermethylation and histone hypoacetylation contribute to pancreatic-duodenal homeobox 1 silencing in gastric cancer. |
2010 |
Carcinogenesis |
pmid:20622005
|
Kim YH et al. |
Sodium butyrate sensitizes TRAIL-mediated apoptosis by induction of transcription from the DR5 gene promoter through Sp1 sites in colon cancer cells. |
2004 |
Carcinogenesis |
pmid:15142888
|
Gastaldi T et al. |
Plakoglobin is differentially expressed in alveolar and embryonal rhabdomyosarcoma and is regulated by DNA methylation and histone acetylation. |
2006 |
Carcinogenesis |
pmid:16537559
|
Grassi G et al. |
Inhibitors of DNA methylation and histone deacetylation activate cytomegalovirus promoter-controlled reporter gene expression in human glioblastoma cell line U87. |
2003 |
Carcinogenesis |
pmid:12869421
|
Kwon O et al. |
NF-kappaB inhibition increases chemosensitivity to trichostatin A-induced cell death of Ki-Ras-transformed human prostate epithelial cells. |
2006 |
Carcinogenesis |
pmid:16774937
|
Chen CQ et al. |
Pure curcumin increases the expression of SOCS1 and SOCS3 in myeloproliferative neoplasms through suppressing class I histone deacetylases. |
2013 |
Carcinogenesis |
pmid:23430957
|
Thakur VS et al. |
Green tea polyphenols causes cell cycle arrest and apoptosis in prostate cancer cells by suppressing class I histone deacetylases. |
2012 |
Carcinogenesis |
pmid:22114073
|
Sharma A et al. |
Trichostatin-A modulates claudin-1 mRNA stability through the modulation of Hu antigen R and tristetraprolin in colon cancer cells. |
2013 |
Carcinogenesis |
pmid:23880304
|
Derks S et al. |
Promoter CpG island hypermethylation- and H3K9me3 and H3K27me3-mediated epigenetic silencing targets the deleted in colon cancer (DCC) gene in colorectal carcinogenesis without affecting neighboring genes on chromosomal region 18q21. |
2009 |
Carcinogenesis |
pmid:19329758
|
Jensen TJ et al. |
Epigenetic remodeling during arsenical-induced malignant transformation. |
2008 |
Carcinogenesis |
pmid:18448484
|
Bhakat KK and Mitra S |
CpG methylation-dependent repression of the human O6-methylguanine-DNA methyltransferase gene linked to chromatin structure alteration. |
2003 |
Carcinogenesis |
pmid:12807730
|
Xiang N et al. |
Selenite reactivates silenced genes by modifying DNA methylation and histones in prostate cancer cells. |
2008 |
Carcinogenesis |
pmid:18676679
|
Nandakumar V et al. |
(-)-Epigallocatechin-3-gallate reactivates silenced tumor suppressor genes, Cip1/p21 and p16INK4a, by reducing DNA methylation and increasing histones acetylation in human skin cancer cells. |
2011 |
Carcinogenesis |
pmid:21209038
|
Liu T et al. |
Regulation of Cdx2 expression by promoter methylation, and effects of Cdx2 transfection on morphology and gene expression of human esophageal epithelial cells. |
2007 |
Carcinogenesis |
pmid:16990345
|
Kamitani H et al. |
Expression of 15-lipoxygenase-1 is regulated by histone acetylation in human colorectal carcinoma. |
2001 |
Carcinogenesis |
pmid:11159758
|
Kaichi S et al. |
Cell line-dependent differentiation of induced pluripotent stem cells into cardiomyocytes in mice. |
2010 |
Cardiovasc. Res. |
pmid:20547733
|
Becker JR et al. |
In vivo natriuretic peptide reporter assay identifies chemical modifiers of hypertrophic cardiomyopathy signalling. |
2012 |
Cardiovasc. Res. |
pmid:22198505
|
Chahine MN et al. |
Nuclear pore rearrangements and nuclear trafficking in cardiomyocytes from rat and human failing hearts. |
2015 |
Cardiovasc. Res. |
pmid:25341891
|
Song S et al. |
Trichostatin A enhances proliferation and migration of vascular smooth muscle cells by downregulating thioredoxin 1. |
2010 |
Cardiovasc. Res. |
pmid:19633316
|
Zhao TC et al. |
Inhibition of histone deacetylases triggers pharmacologic preconditioning effects against myocardial ischemic injury. |
2007 |
Cardiovasc. Res. |
pmid:17884027
|
Zhang HS et al. |
Exit from G1 and S phase of the cell cycle is regulated by repressor complexes containing HDAC-Rb-hSWI/SNF and Rb-hSWI/SNF. |
2000 |
Cell |
pmid:10778858
|
Ekwall K et al. |
Transient inhibition of histone deacetylation alters the structural and functional imprint at fission yeast centromeres. |
1997 |
Cell |
pmid:9428524
|
Nagy L et al. |
Nuclear receptor repression mediated by a complex containing SMRT, mSin3A, and histone deacetylase. |
1997 |
Cell |
pmid:9150137
|
Mostovich LA et al. |
Integrin alpha9 (ITGA9) expression and epigenetic silencing in human breast tumors. |
2011 Sep-Oct |
Cell Adh Migr |
pmid:21975548
|
Nieto-Pelegrin E et al. |
Nck adaptors, besides promoting N-WASP mediated actin-nucleation activity at pedestals, influence the cellular levels of enteropathogenic Escherichia coli Tir effector. |
2014 |
Cell Adh Migr |
pmid:25482634
|
Zhang C et al. |
Decreased PADI4 mRNA association with global hypomethylation in hepatocellular carcinoma during HBV exposure. |
2013 |
Cell Biochem. Biophys. |
pmid:22907585
|
Kotantaki P and Mosialos G |
The expression of tumor suppressor gene Cyld is upregulated by histone deacetylace inhibitors in human hepatocellular carcinoma cell lines. |
2016 |
Cell Biochem. Funct. |
pmid:27570065
|
Jeong SG and Cho GW |
Trichostatin A modulates intracellular reactive oxygen species through SOD2 and FOXO1 in human bone marrow-mesenchymal stem cells. |
2015 |
Cell Biochem. Funct. |
pmid:25515622
|
Cheng YW et al. |
The histone deacetylase inhibitor panobinostat exerts anticancer effects on esophageal squamous cell carcinoma cells by inducing cell cycle arrest. |
2018 |
Cell Biochem. Funct. |
pmid:30484863
|
Kovács P and Csaba G |
The effect of histone deacetylase inhibitor trichostatin A (TSA) on the incorporation of 32P (Pi) and 3H-palmitic acid into the phospholipids of Tetrahymena. |
2008 Jan-Feb |
Cell Biochem. Funct. |
pmid:17191269
|
Gao A et al. |
Epigenetic modification involved in benzene-induced apoptosis through regulating apoptosis-related genes expression. |
2011 |
Cell Biol. Int. |
pmid:21143203
|
Sun DF et al. |
Inhibition of mTOR signalling potentiates the effects of trichostatin A in human gastric cancer cell lines by promoting histone acetylation. |
2014 |
Cell Biol. Int. |
pmid:24030871
|
Xing M et al. |
Histone deacetylase inhibitor stimulates E2 and P4 secretion in sika deer ovarian granulosa cells at a moderate dose. |
2018 |
Cell Biol. Int. |
pmid:29064603
|
Jugová A et al. |
Effects of epigenetic-based anti-cancer drugs in leukaemia and multiple myeloma cells. |
2011 |
Cell Biol. Int. |
pmid:21635225
|
Li Z et al. |
Epigenetic inactivation of PCDH10 in human prostate cancer cell lines. |
2011 |
Cell Biol. Int. |
pmid:21314642
|
Lee TB et al. |
Histone H4 deacetylation down-regulates catalase gene expression in doxorubicin-resistant AML subline. |
2012 |
Cell Biol. Toxicol. |
pmid:21968610
|
Stefanovsky V and Moss T |
Regulation of rRNA synthesis in human and mouse cells is not determined by changes in active gene count. |
2006 |
Cell Cycle |
pmid:16582637
|
Wang Q et al. |
Histone deacetylation is required for orderly meiosis. |
2006 |
Cell Cycle |
pmid:16582639
|
Santiago A et al. |
Identification of two independent SUMO-interacting motifs in Daxx: evolutionary conservation from Drosophila to humans and their biochemical functions. |
2009 |
Cell Cycle |
pmid:19106612
|
Bayles R et al. |
Histone modifications regulate the norepinephrine transporter gene. |
2010 |
Cell Cycle |
pmid:21088495
|
Bagui TK et al. |
Inhibition of p27Kip1 gene transcription by mitogens. |
2009 |
Cell Cycle |
pmid:19158484
|
Zhang CZ et al. |
Interaction between ZBP-89 and p53 mutants and its contribution to effects of HDACi on hepatocellular carcinoma. |
2012 |
Cell Cycle |
pmid:22214764
|
Wang Q et al. |
The spatial relationship between heterochromatin protein 1 alpha and histone modifications during mouse oocyte meiosis. |
2008 |
Cell Cycle |
pmid:18239470
|
Robbins AR et al. |
Inhibitors of histone deacetylases alter kinetochore assembly by disrupting pericentromeric heterochromatin. |
2005 |
Cell Cycle |
pmid:15846093
|
McKenzie L et al. |
p53-dependent repression of polo-like kinase-1 (PLK1). |
2010 |
Cell Cycle |
pmid:20962589
|
Wang Q et al. |
Histone phosphorylation and pericentromeric histone modifications in oocyte meiosis. |
2006 |
Cell Cycle |
pmid:16969090
|
Fabre C et al. |
A novel effect of DNA methyltransferase and histone deacetylase inhibitors: NFkappaB inhibition in malignant myeloblasts. |
2008 |
Cell Cycle |
pmid:18641459
|
Wang N and Tilly JL |
Epigenetic status determines germ cell meiotic commitment in embryonic and postnatal mammalian gonads. |
2010 |
Cell Cycle |
pmid:20009537
|
Kato N et al. |
Regulation of Chk2 gene expression in lymphoid malignancies: involvement of epigenetic mechanisms in Hodgkin's lymphoma cell lines. |
2004 |
Cell Death Differ. |
pmid:15153943
|
Adi Harel S et al. |
Reactivation of epigenetically silenced miR-512 and miR-373 sensitizes lung cancer cells to cisplatin and restricts tumor growth. |
2015 |
Cell Death Differ. |
pmid:25591738
|
Rebbaa A et al. |
The role of histone acetylation versus DNA damage in drug-induced senescence and apoptosis. |
2006 |
Cell Death Differ. |
pmid:16557274
|
Grande A et al. |
A functionally active RARalpha nuclear receptor is expressed in retinoic acid non responsive early myeloblastic cell lines. |
2001 |
Cell Death Differ. |
pmid:11313705
|
Ajiro K et al. |
Reciprocal epigenetic modification of histone H2B occurs in chromatin during apoptosis in vitro and in vivo. |
2010 |
Cell Death Differ. |
pmid:20057502
|
Jori FP et al. |
RB and RB2/p130 genes demonstrate both specific and overlapping functions during the early steps of in vitro neural differentiation of marrow stromal stem cells. |
2005 |
Cell Death Differ. |
pmid:15459751
|
Xu Y et al. |
SHP-1 sensitizes MCF-7 cells to trichostatin A-induced apoptosis by modulating PI3K-dependent events. |
2003 |
Cell Death Differ. |
pmid:14502244
|
Bernhard D et al. |
Interaction between dexamethasone and butyrate in apoptosis induction: non-additive in thymocytes and synergistic in a T cell-derived leukemia cell line. |
1999 |
Cell Death Differ. |
pmid:10453071
|
Wu P et al. |
Ubiquitin B: an essential mediator of trichostatin A-induced tumor-selective killing in human cancer cells. |
2010 |
Cell Death Differ. |
pmid:19798105
|
Shu G et al. |
Zac1 is a histone acetylation-regulated NF-κB suppressor that mediates histone deacetylase inhibitor-induced apoptosis. |
2011 |
Cell Death Differ. |
pmid:21546906
|
Lee MS et al. |
Stabilization of p21 (Cip1/WAF1) following Tip60-dependent acetylation is required for p21-mediated DNA damage response. |
2013 |
Cell Death Differ. |
pmid:23238566
|
Montero-Melendez T et al. |
Gene expression signature-based approach identifies a pro-resolving mechanism of action for histone deacetylase inhibitors. |
2013 |
Cell Death Differ. |
pmid:23222458
|
Bernhard D et al. |
Inhibition of histone deacetylase activity enhances Fas receptor-mediated apoptosis in leukemic lymphoblasts. |
2001 |
Cell Death Differ. |
pmid:11598799
|
Zhu QY et al. |
C6-ceramide synergistically potentiates the anti-tumor effects of histone deacetylase inhibitors via AKT dephosphorylation and α-tubulin hyperacetylation both in vitro and in vivo. |
2011 |
Cell Death Dis |
pmid:21368888
|
Chen X et al. |
The epigenetic modifier trichostatin A, a histone deacetylase inhibitor, suppresses proliferation and epithelial-mesenchymal transition of lens epithelial cells. |
2013 |
Cell Death Dis |
pmid:24157878
|
Fujiki R et al. |
A proapoptotic effect of valproic acid on progenitors of embryonic stem cell-derived glutamatergic neurons. |
2013 |
Cell Death Dis |
pmid:23788034
|
Sachweh MC et al. |
Incompatible effects of p53 and HDAC inhibition on p21 expression and cell cycle progression. |
2013 |
Cell Death Dis |
pmid:23470540
|
Ma T et al. |
Suppression of BMP-7 by histone deacetylase 2 promoted apoptosis of renal tubular epithelial cells in acute kidney injury. |
2017 |
Cell Death Dis |
pmid:29072686
|
Zhang Z et al. |
Stemness and inducing differentiation of small cell lung cancer NCI-H446 cells. |
2013 |
Cell Death Dis |
pmid:23681228
|
Bordonaro M et al. |
Butyrate-induced apoptotic cascade in colonic carcinoma cells: modulation of the beta-catenin-Tcf pathway and concordance with effects of sulindac and trichostatin A but not curcumin. |
1999 |
Cell Growth Differ. |
pmid:10547075
|